Aspirin (Disprin Cardiocare, Disprin Regular Strenght, Disprin Extra Strength, Disprin Melts)
Aspirin
Reckitt Benckinser Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Reckitt Benckinser Pharmaceuticals (Pty) Ltd
- Certificate holder
- Reckitt Benckiser Pharmaceuticals (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Disprin cardiocare EACH TABLET CONTAINS ASPIRIN 100 mg | 100 mgTablets | 31007131/2.8/0071Approved 17 April 2024 | Registered | Not determined | PIPIL |
| Disprin regular strenght 300 MG TABLET ASPIRIN 300 MG | 300 mg | B0570B/2.7/570 | Registered | Not determined | None |
| Disprin extra strength 500 MG EACH TABLET CONTAINS ASPIRIN 500 mg | 500 mg | M0292M/2.7/0292 | Registered | Not determined | None |
| Disprin melts EACH TABLET CONTAINS ASPIRIN 300 mg | 300 mgTablets | R0099R/2.8/99Approved 6 February 2024 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S2: Aspirin
- the treatment of children or adolescents; and
- the prophylaxis of cardiovascular disease in adults (S0)
Consolidated Schedules 06 July 2026, lines 1616 to 1620
5 of 7 approved products with this ingredient carry S3 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.